Nowości w diagnostyce jaskry – czy można realnie ocenić ryzyko wystąpienia jaskry?
Autorzy: Małgorzata Ryk, Alina Szewczuk, Anna Zaleska-Żmijewska

New Trends in Glaucoma Diagnosis and Risk Assessment.

Wydanie 3/2020
str. 29 – 33

Autorzy: Małgorzata Ryk1,2, Alina Szewczuk1, Anna Zaleska-Żmijewska1,2

1. Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie.
Kierownik: prof. dr hab. n. med. Jacek P. Szaflik.
2. Katedra i Klinika Okulistyki Wydziału Lekarskiego Warszawskiego Uniwersytetu Medycznego.
Kierownik: prof. dr hab. n. med. Jacek P. Szaflik.


Glaucoma is the leading cause of irreversible blindness worldwide. More than a half of the patients affected by glaucoma remain undiagnosed as it usually becomes symptomatic only in its severe stages. Therefore, early diagnosis and monitoring are essential to prevent vision loss. The glaucoma management is challenging, since there is no single specific test that could be regarded as a perfect reference to detect and predict the progression of glaucoma. This review summarizes recent findings with regards to stereophotography, optical coherence tomography, angio-optical coherence tomography, glaucoma diagnostic, Heidelberg retina tomography, Pattern electroretinogram and visual field examinations. Additionally, we present an overview of the genetic etiology of glaucoma. Understanding glaucoma molecular basis and its genetic markers could increase our knowledge of the disease and its progression. Gene-based diagnostic and screening tests are considered as the future tools to identify individuals at risk of glaucoma.

Keywords: glaucoma, glaucoma diagnosis, optical coherence tomography (OCT), gene-based diagnostic.
Słowa kluczowe: jaskra, diagnostyka jaskry, optyczna koherentna tomografia, diagnostyka genetyczna.